Loss of responsiveness to TGFβ antiproliferative effects is believed to be important in carcinogenesis, yet the known mechanisms of TGFβ resistance happen late in the progression of established liver cancer [55,8]. The gene discussed is TGFB1; the disease is liver cancer.